Formulation development of a continuously manufactured orodispersible film containing warfarin sodium for individualized dosing.
Continuous manufacturing
Film thickness
Individualized medicine
Oral film
Orodispersible film
Personalized medicine
Solvent casting
Tensile test
Warfarin sodium
Journal
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
09
08
2018
revised:
14
12
2018
accepted:
13
01
2019
pubmed:
21
1
2019
medline:
31
5
2019
entrez:
21
1
2019
Statut:
ppublish
Résumé
Continuously manufactured orodispersible films (ODFs) offer a promising approach for individualized therapy with an easy to administer solid dosage form. The aim of this study was to develop a long ODF containing warfarin sodium to enable safe and more flexible dosing. Formulation development was conducted systematically for the continuous film coating process. A continuously working pilot-scale coating bench was used for film manufacturing and the viscosities of the polymer solutions were investigated to obtain processible formulations. The investigation of the mechanical properties of the long film was an integral part of the study, because the handling of the long film during flexible dosing differs distinctly from the handling of a single dosed ODF. The secant modulus and the yield stress were evaluated as parameters with high information value about the deformation behavior of the ODF. A long warfarin ODF was successfully produced using the pilot-scale coating bench equipped with an optical probe for in-line film thickness measurement. It was feasible to use the principle of a tape dispenser for flexible and, therefore, individualized dosing as proof of concept. Combining the long ODF with a dosing device allows individualized therapy with warfarin for all age groups manageable by the patient himself.
Identifiants
pubmed: 30660692
pii: S0939-6411(18)30998-6
doi: 10.1016/j.ejpb.2019.01.011
pii:
doi:
Substances chimiques
Anticoagulants
0
Drug Carriers
0
Warfarin
5Q7ZVV76EI
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
93-101Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.